With needleless systems, the stress and anxiety often associated with injections can be significantly reduced, potentially improving treatment adherence and health outcomes
But this protection is not automatic
To view or add a comment, sign in The next GLP-1 race is not only which molecule performs better. It is also becoming a formulation race: oral small molecules peptide injectables multi-agonist receptor profiles adherence and real-world protocol constraints Lillys ACHIEVE-3 data put this shift into focus
Patients who have suffered from the undisclosed side effects of Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda and Trulicity often must make many ER visits, have severe quality of life issues, and need multiple medications for the rest of their lives
The authors extend their sincere appreciation to the dedicated staff at the Health Data Science Center of Chung Shan Medical University Hospital for their invaluable assistance throughout this study